ALICIA PARKS: Open Payments
NPI 1770868796 · TAMPA, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,336 in 100 payments from 13 companies in 2025. Trend: 2023 $1,793 · 2024 $2,195 · 2025 $2,336
Food & beverage: $2,224Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 33 | $704 |
| E.R. Squibb & Sons, L.L.C. | 15 | $398 |
| Neurocrine BioSciences, Inc. | 12 | $350 |
| Otsuka America Pharmaceutical, Inc. | 12 | $341 |
| Janssen Pharmaceuticals, Inc | 7 | $154 |
| Alkermes, Inc. | 6 | $116 |
| ABBVIE INC. | 6 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Lundbeck LLC | 2 | $34 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
Products named: AUSTEDO XR, COBENFY, INGREZZA, ABILIFY ASIMTUFII, UZEDY, INVEGA SUSTENNA, VRAYLAR, CAPLYTA.
Industry payments across DC — which companies pay providers there.
